Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

CRISPR Therapeutics (Switzerland)

InstitutionResearch output, impact & collaborations

CRISPR Therapeutics (Switzerland) is a research organisation in Basel, CH. OpenAlex records 120 works and 10,687 citations for it. 94 researchers list it as their most recent affiliation.

120
Works
10,687
Citations
94
Researchers
5
Avg h-index

How has CRISPR Therapeutics (Switzerland)'s publication output changed over time?

ScholarIQpublication output · 2008–2022

Output grew0% over the shown period — from 1 works in 2008 to 1 in 2022.

1
1
4
1
1
1
1
2008201020122013201720182022

Who are the most-cited researchers behind CRISPR Therapeutics (Switzerland)?

ScholarIQtop researchers by citations
1
Ainsley Ross · Glioma Diagnosis and Treatment
12 works365 citations

What are the most-cited papers on CRISPR Therapeutics (Switzerland)?

ScholarIQmost cited works
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
Andrew D. Norden, Jan Drappatz, Alona Muzikansky, Karly David, Mary Gerard, M. Brenna McNamara, Phuong Phan, Ainsley Ross, Santosh Kesari, Patrick Y. Wen
S175922936. 2008139 Citations
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson
Joshua J. Field, Gene Lin, Maureen Okam, Elaine M. Majerus, Jeffrey R. Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan
Blood. 2013100 CitationsOPEN ACCESS
Comparative rates of adverse events with different formulations of intravenous iron
Maureen Okam, Elyse Mandell, Nathanael D. Hevelone, Wentz Rachel, Ainsley Ross, Gregory A. Abel
American Journal of Hematology. 201258 CitationsOPEN ACCESS
CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study
Joseph P. McGuirk, Constantine S. Tam, Nicolaus Kröger, Peter A. Riedell, Hemant S. Murthy, Phoebe Joy Ho, Joseph Maakaron, Edmund K. Waller, Farrukh T. Awan, Paul Shaughnessy, Armin Ghobadi, Michael Bishop, Ana Alfonso Piérola, Michael Dickinson, Praveen Ramakrishnan Geethakumari, Ainsley Ross, William B. Stevens, Huansheng Xu, Anna Ma, Sarah Beaussant-Cohen, Richard T. Maziarz, Carlos Bachier
Blood. 202257 Citations
Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.
David G. Nathan, Joshua J. Field, Gene Lin, Donna Neuberg, Elaine M. Majerus, Onyinye Onyekwere, Jeffrey R. Keefer, Maureen Okam, Ainsley Ross, Joel Linden
PubMed. 20128 CitationsOPEN ACCESS

How much of the research on CRISPR Therapeutics (Switzerland) is open access?

ScholarIQopen access share
30%OPEN ACCESS
Gold
0%
Green
10%
Hybrid
0%
Bronze
20%
Closed
70%

Related on ScholarIQ

CRISPR and Genetic Engineering
Top Topic
CAR-T cell therapy research
Top Topic
Genetically Modified Organisms Research
Top Topic
Biomedical Ethics and Regulation
Top Topic
Virus-based gene therapy research
Top Topic
Innovation and Socioeconomic Development
Top Topic
470M+ articles · free account